<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3307">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03063853</url>
  </required_header>
  <id_info>
    <org_study_id>0150-16- WOMC</org_study_id>
    <nct_id>NCT03063853</nct_id>
  </id_info>
  <brief_title>Removal of Surgical Staples After Cesarean Delivery. POD4 or POD8. A Randomized Control Trial.</brief_title>
  <acronym>ROCD</acronym>
  <official_title>Removal of Surgical Staples After Cesarean Delivery. POD4 or POD8. A Randomized Control Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <brief_summary>
    <textblock>
      The optimal choice of skin closure at cesarean delivery has not yet been determined. This
      study aim to study the wound complications and scar healing after Surgical staples removal
      at postoperative day 4 and day 8 .

      A randomized control trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled trial in which pregnant women undergoing a scheduled Elective
      cesarean delivery were assigned to skin closure with surgical staples and were randomally
      assigned to the day of removal of surgical staples. Postoperative day 4 VS. Postoperative
      day 8 .

      Outcome assessors were blinded to group allocation. Scars will be evaluated after 8 weeks.
      Primary outcome measures is Patient and Observer Scar Assessment Scale (POSAS) scores.
      Secondary outcome measures are complications of surgical site infection (SSI) or wound
      disruption (hematoma or seroma).

      A group of 104 women is needed in order to achieve a clinically signiÔ¨Åcant effect with a
      power of 80%.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient and Observer Scar Assessment Scale (POSAS) scores.</measure>
    <time_frame>8 weeks postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications of surgical site infection (SSI) or wound disruption (hematoma or seroma).</measure>
    <time_frame>8 weeks postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Cesarean Section; Wound, Infection (Following Delivery)</condition>
  <arm_group>
    <arm_group_label>POD4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>REMOVAL OF SURGICAL STAPLES AT POSTOPERATIVE DAY 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>POD8</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>REMOVAL OF SURGICAL STAPLES AT POSTOPERATIVE DAY 8</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Removal of surgical clips at day 4 postop vs day 8</intervention_name>
    <arm_group_label>POD4</arm_group_label>
    <arm_group_label>POD8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Elective cesarean delivery</intervention_name>
    <arm_group_label>POD4</arm_group_label>
    <arm_group_label>POD8</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cesarean delivery

          -  previous cesarean delivery performed using the Pfannenstiel method

          -  36-41 weeks of gestation based on first trimester ultrasound and a viable fetus.

        Exclusion Criteria:

          -  emergency cesarean delivery

          -  clinical signs of infection at the time of CD, uncontrolled

          -  vunblanaced diabetes mellitus

          -  history of keloids
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hadas Miremberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wolfson Medical Center- Tel Aviv University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hadas Miremberg, MD</last_name>
    <phone>972526741740</phone>
    <email>dasile2@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wolfson medical center</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadas Miremberg, MD</last_name>
      <phone>972526741740</phone>
      <email>dasile2@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>February 23, 2017</lastchanged_date>
  <firstreceived_date>February 22, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
